OAM
MIRM icon

Oppenheimer Asset Management’s Mirum Pharmaceuticals MIRM Stock Holding History

Oppenheimer Asset Management’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$239K Buy
+2,040
New +$205K ﹤0.01% 1048
2026
Q1 		– Sell
-3,087
Closed -$244K – 1151
2025
Q4 		$244K Buy
3,087
+13
+0.4% +$933 ﹤0.01% 962
2025
Q3 		$225K Buy
+3,074
New +$195K ﹤0.01% 1068

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Oppenheimer Asset Management's MIRM Position: Q2 2026 in Review

Oppenheimer Asset Management opened a new position in Mirum Pharmaceuticals (MIRM) in Q2 2026: 2,040 shares worth $239K. The stake represents ﹤0.01% of the portfolio and ranks #1048 among its holdings. This is a return to the name: Oppenheimer Asset Management previously reported a position in MIRM as recently as Q4 2025.

Oppenheimer Asset Management first reported a position in MIRM in Q3 2025 and has held it in 3 quarters since. The position peaked at $244K in Q4 2025. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • Oppenheimer Asset Management held 2,040 shares of Mirum Pharmaceuticals worth $239K as of Q2 2026.
  • Mirum Pharmaceuticals was a new Oppenheimer Asset Management position in Q2 2026.
  • Mirum Pharmaceuticals made up ﹤0.01% of Oppenheimer Asset Management's portfolio in Q2 2026, its #1048 holding.
  • Oppenheimer Asset Management first reported a position in Mirum Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
  • Oppenheimer Asset Management's Mirum Pharmaceuticals position peaked at $244K in Q4 2025.
  • 327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Oppenheimer Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.